Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $545.61 million. The enterprise value is $232.79 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 53.18 million shares outstanding. The number of shares has increased by 30.63% in one year.
| Current Share Class | 53.18M |
| Shares Outstanding | 53.18M |
| Shares Change (YoY) | +30.63% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 4.16% |
| Owned by Institutions (%) | 37.50% |
| Float | 21.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.68 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 22.78 |
| Quick Ratio | 22.51 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.04% and return on invested capital (ROIC) is -19.58%.
| Return on Equity (ROE) | -27.04% |
| Return on Assets (ROA) | -19.00% |
| Return on Invested Capital (ROIC) | -19.58% |
| Return on Capital Employed (ROCE) | -34.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.61M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.86% in the last 52 weeks. The beta is 1.17, so TYRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -40.86% |
| 50-Day Moving Average | 9.81 |
| 200-Day Moving Average | 16.12 |
| Relative Strength Index (RSI) | 54.64 |
| Average Volume (20 Days) | 303,326 |
Short Selling Information
The latest short interest is 4.35 million, so 8.19% of the outstanding shares have been sold short.
| Short Interest | 4.35M |
| Short Previous Month | 3.94M |
| Short % of Shares Out | 8.19% |
| Short % of Float | 20.58% |
| Short Ratio (days to cover) | 12.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -113.71M |
| Pretax Income | -80.88M |
| Net Income | -96.44M |
| EBITDA | -113.17M |
| EBIT | -113.71M |
| Earnings Per Share (EPS) | -$1.63 |
Full Income StatementBalance Sheet
The company has $318.94 million in cash and $6.12 million in debt, giving a net cash position of $312.82 million or $5.88 per share.
| Cash & Cash Equivalents | 318.94M |
| Total Debt | 6.12M |
| Net Cash | 312.82M |
| Net Cash Per Share | $5.88 |
| Equity (Book Value) | 323.53M |
| Book Value Per Share | 6.09 |
| Working Capital | 310.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$73.20 million and capital expenditures -$542,000, giving a free cash flow of -$73.75 million.
| Operating Cash Flow | -73.20M |
| Capital Expenditures | -542,000 |
| Free Cash Flow | -73.75M |
| FCF Per Share | -$1.39 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |